Literature DB >> 11384248

Preparation and properties of S-nitroso-L-cysteine ethyl ester, an intracellular nitrosating agent.

R Clancy1, A I Cederbaum, D A Stoyanovsky.   

Abstract

In this report, a protocol for the preparation of the hydrochloride of S-nitroso-L-cysteine ethyl ester (SNCEE.HCl; 2) is presented. The synthesis of 2 has been targeted because S-nitroso-L-cysteine (SNC; 2b), which is extensively used for trans-S-nitrosation of thiol-containing proteins, has a limited ability of crossing cellular membranes. The nitrosothiol 2 was prepared via direct S-nitrosation of the hydrochloride of L-cysteine ethyl ester (CEE.HCl; 1a) with ethyl nitrite. 2 is relatively stable in crystal form and when neutralized to SNCEE (2a) in aqueous solutions treated with chelators of metal ions. Traces of metal ions, however, triggered the decomposition of 2a to nitric oxide and a S-centered radical, which were detected by ESR spectrometry. In contrast to 2b, 2a is a lipophilic compound that was taken up by human neutrophils. The latter process was paralleled by inhibition of the NADPH oxidase-dependent generation of superoxide anion radicals, presumably via reaction(s) of intracellular trans-S-nitrosation. Intracellular accumulation of S-nitrosothiols was observed with 2a but not with 2b. It is expected that the use of 2a will be advantageous when intracellular reactions of trans-S-nitrosation are to be studied.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384248     DOI: 10.1021/jm000463f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

Review 1.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

2.  Multimodal control of Cdc25A by nitrosative stress.

Authors:  Robert J Tomko; John S Lazo
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

3.  Decomposition of S-nitrosocysteine via S- to N-transnitrosation.

Authors:  Lisa A Peterson; Tanja Wagener; Helmut Sies; Wilhelm Stahl
Journal:  Chem Res Toxicol       Date:  2007-04-18       Impact factor: 3.739

4.  The solid-state molecular structure of the S-nitroso derivative of L-cysteine ethyl ester hydrochloride.

Authors:  Jun Yi; Masood A Khan; Jonghyuk Lee; George B Richter-Addo
Journal:  Nitric Oxide       Date:  2005-06       Impact factor: 4.427

5.  Thioredoxin-related protein of 14 kDa is an efficient L-cystine reductase and S-denitrosylase.

Authors:  Irina Pader; Rajib Sengupta; Marcus Cebula; Jianqiang Xu; Jon O Lundberg; Arne Holmgren; Katarina Johansson; Elias S J Arnér
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

6.  Nitric oxide and thioredoxin type 1 modulate the activity of caspase 8 in HepG2 cells.

Authors:  Rajib Sengupta; Timothy R Billiar; Valerian E Kagan; Detcho A Stoyanovsky
Journal:  Biochem Biophys Res Commun       Date:  2009-12-11       Impact factor: 3.575

Review 7.  Solid-phase capture for the detection and relative quantification of S-nitrosoproteins by mass spectrometry.

Authors:  J Will Thompson; Michael T Forrester; M Arthur Moseley; Matthew W Foster
Journal:  Methods       Date:  2012-10-11       Impact factor: 3.608

8.  Nitric oxide and dihydrolipoic acid modulate the activity of caspase 3 in HepG2 cells.

Authors:  Rajib Sengupta; Timothy R Billiar; James L Atkins; Valerian E Kagan; Detcho A Stoyanovsky
Journal:  FEBS Lett       Date:  2009-10-12       Impact factor: 4.124

9.  L-Cysteine ethyl ester reverses the deleterious effects of morphine on, arterial blood-gas chemistry in tracheotomized rats.

Authors:  James Mendoza; Rachael Passafaro; Santhosh Baby; Alex P Young; James N Bates; Benjamin Gaston; Stephen J Lewis
Journal:  Respir Physiol Neurobiol       Date:  2013-07-23       Impact factor: 1.931

10.  Nitrosative stress suppresses checkpoint activation after DNA synthesis inhibition.

Authors:  Robert J Tomko; Ndang N Azang-Njaah; John S Lazo
Journal:  Cell Cycle       Date:  2009-01-10       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.